US Patent Issued to UNIVERSITE GRENOBLE ALPES, INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE, CENTRE HOSPITALIER REGIONAL DE GRENOBLE, UNIVERSITE PARIS-SACLAY on Feb. 17 for "Acyl-protein thioesterase inhibitor for the treatment and/or prevention of Huntington's disease" (French Inventors)

ALEXANDRIA, Va., Feb. 17 -- United States Patent no. 12,551,479, issued on Feb. 17, was assigned to UNIVERSITE GRENOBLE ALPES (Saint Martin d'Heres, France), INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (Paris), CENTRE HOSPITALIER REGIONAL DE GRENOBLE (La Tronche, France) and UNIVERSITE PARIS-SACLAY (Gif-sur-Yvette, France).

"Acyl-protein thioesterase inhibitor for the treatment and/or prevention of Huntington's disease" was invented by Frederic Saudou (Grenoble, France) and Amandine Virlogeux (Craponne, France).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed is an inhibitor of the acyl-protein thioesterase APT1, ML-348, of formula A:for use in the treatment and/or prevention of a diseas...